NCT02872597View on ClinicalTrials.gov

Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 5, 2016

Primary Completion Date

August 15, 2018

Study Completion Date

August 16, 2018

Conditions

Status Asthmaticus

Interventions

DRUG

Ipratropium

DRUG

0.9% Sodium Chloride

DRUG

Albuterol

"albuterol prescribed by the clinical team per our PICU's Asthma Carepath"

DRUG

corticosteroids

systemic (IV or enteral) corticosteroid prescribed by the clinical team, typically methylprednisolone IV

Trial Locations (1)

44106

Rainbow Babies and Children's Hospital (of Univ. Hospitals Case Med. Center), Cleveland

All Listed Sponsors

lead

University Hospitals Cleveland Medical Center

OTHER

NCT02872597 - Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus | Biotech Hunter | Biotech Hunter